News
MYNZ
1.224
-0.50%
-0.006
Weekly Report: what happened at MYNZ last week (1208-1212)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/10 21:05
Weekly Report: what happened at MYNZ last week (1201-1205)?
Weekly Report · 12/08 09:14
Mainz Biomed files $150M mixed securities shelf
TipRanks · 12/05 22:10
Mainz Biomed announces ColoAlert added to portfolio of DoctorBox
TipRanks · 12/02 13:27
Weekly Report: what happened at MYNZ last week (1124-1128)?
Weekly Report · 12/01 09:14
Mainz Biomed B.V. Amends Articles to Boost Share Capital
TipRanks · 11/26 22:27
Weekly Report: what happened at MYNZ last week (1117-1121)?
Weekly Report · 11/24 09:15
Mainz Biomed, OncoVanguard8 agree to bring ColoAlert to South America
TipRanks · 11/18 14:30
Weekly Report: what happened at MYNZ last week (1110-1114)?
Weekly Report · 11/17 09:14
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/13 17:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/13 12:06
Mainz Biomed To Present Flagship Product, ColoAlert, At MEDICA 2025
NASDAQ · 11/12 14:25
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
Barchart · 11/12 07:01
Weekly Report: what happened at MYNZ last week (1103-1107)?
Weekly Report · 11/10 09:14
Weekly Report: what happened at MYNZ last week (1027-1031)?
Weekly Report · 11/03 09:14
Mainz Biomed’s Colorectal Cancer Test: A Promising Pilot Study Update
TipRanks · 10/27 19:41
Mainz Biomed’s Colorectal Cancer Screening Test: A New Hope for Early Detection
TipRanks · 10/27 17:26
Weekly Report: what happened at MYNZ last week (1020-1024)?
Weekly Report · 10/27 09:15
Weekly Report: what happened at MYNZ last week (1013-1017)?
Weekly Report · 10/20 09:14
More
Webull provides a variety of real-time MYNZ stock news. You can receive the latest news about Mainz Biomed NV through multiple platforms. This information may help you make smarter investment decisions.
About MYNZ
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.